Complications
Procedures (103) Patients (54)
Liver bleeds (req�d intervention) 9/103 (9%) 9/54 (18%)
Gallbladder opacification 2/103 (2%) 2/54 (4%)
Gallbladder hematoma 1/103 (1%) 1/54 (2%)
Hemobilia 1/103 (1%) 1/54 (2%)
Severe neutropenia (< 500) 2/54 (4%)
Elevated creatinine 2/54 (4%)
Mouth ulceration 45/54 (87%)
Dyslipidemia (Statin) 23/54 (44%)
Transient LFT rise 48/103 (47%) 29/54 (37%)
Liver MRI�s - fatty changes + wedge perfusion anomalies - under active study
Branch portal vein thrombosis 3/103 (3%) 3/54 (6%)
Ileal ulcer (sirolimus) 2/54 (4%)
Sensitization (PRA) 1/54 (2%)
No deaths, no cancers, no PTLD, no CMV